bestnom1000x50

research

Latest Articles

Letters_MorgueBody2_list

An organ recipient speaks up

An article on this subject ("On Being Undead," by Jeff Inglis, October 26) needs to be done with great thought and care.

By PORTLAND PHOENIX LETTERS  |  November 02, 2012
ShortTakes_PinkRibbonsInc

Review: Pink Ribbons, Inc.

Near the end of this documentary a woman calls the pink ribbon of breast cancer-awareness a "made in China" tag.
Documenting hypocrisy in the breast-cancer awareness movement
By MILES BOWE  |  June 22, 2012
TJI_eidel_list

At the hip-hop high school

In his new book, Hip Hop Genius: Remixing High School Education , Sam Seidel describes a sign hanging at the juvenile detention facility in Cranston.
Education Dept.
By PHILIP EIL  |  March 16, 2012
short take Abduction

Review: Abduction

Taylor Lautner plays characters with mysterious origins and makes them boring.
Beautiful but boring
By PETER KEOUGH  |  September 30, 2011
contagion 3

Review: Contagion

For all the death and panic, this is a relatively quiet film.
The Traffic of viral outbreak movies
By BRETT MICHEL  |  September 16, 2011
facebook_thumb

Facebook for life

Facebook users have been notably vocal about their privacy concerns, and last week's blow-up over the change in the site's contract produced an outpouring of suspicion, recrimination, and protest.
Facebook is giving away your personal information and at least one data-miner is nervous about privacy.
By MIKE MILIARD  |  February 24, 2009


Super Music Dork! We Want You!

Super Music Dork! We Want You!


Smart intelligent FNX listener, We need your help. Every so often we post a survey of all the different new songs we play. We'd like...
By Keith Dakin  |  December 06, 2007

Obviously you are smarter than us.


Every two weeks, we like to get your opinions on various songs we play. We will give you a list about 25 songs with 7...
By Keith Dakin  |  November 19, 2007
060417_pill_list

Med school drug pushers

You may have heard of a little ongoing row about a Merck drug called Vioxx, which was pulled from the market in 2004 due to evidence that it caused serious heart problems in some users.
How scientists are selling out to drug companies
By DAVID S. BERNSTEIN  |  April 12, 2006